FAQ – Blog

Researchers Investigate Mindfulness as a Promising, Non-invasive Treatment for FSD

Mindfulness could be a viable approach for treating female sexual dysfunction, suggests a recent study in Sexual Medicine Reviews.  Sexual problems for women can be approached in different ways. For example, medications like flibanserin can address desire issues like hypoactive sexual desire disorder. But some women don’t respond to these treatments.  In particular, mindfulness might…

CONTINUE READING

Testosterone Trials Investigate Testosterone’s Effects on Four Outcomes | ISSM

Four studies published recently in JAMA and JAMA Internal Medicine provide new insights on the effects of testosterone therapy on various health outcomes, including memory, bone density, anemia, and coronary artery plaque volume. The studies were part of the Testosterone Trials (T-Trials), a series of seven linked studies involving men over age 65 who had…

CONTINUE READING

Health Benefits of Sex

Good sexual health is part of good overall health. That’s a fact we consider often here at SexHealthMatters.org. But have you ever wondered just how having sex is good for your health?  Here are just some of the benefits:Sex can be a great stress reliever.  Human and animal studies have shown that having more sex can…

CONTINUE READING

Localized Prostate Cancer Treatment and Patient-Reported Outcomes After 3 Years

IMPORTANCEUnderstanding the adverse effects of contemporary approaches to localized prostate cancer treatment could inform shared decision making.  OBJECTIVETo compare functional outcomes and adverse effects associated with radical prostatectomy, external beam radiation therapy (EBRT), and active surveillance.  DESIGN, SETTING, AND PARTICIPANTSProspective, population-based, cohort study involving 2550 men (≤80 years) diagnosed in 2011-2012 with clinical stage cT1-2, localized prostate cancer,…

CONTINUE READING

FDA Approves Intrarosa for Sexual Pain in Postmenopausal Women

Postmenopausal women who experience moderate to severe pain during intercourse may have a new treatment option.  Last November, the U.S. Food and Drug Administration (FDA) approved a drug called Intrarosa (prasterone) for sexual pain caused by vulvar and vaginal atrophy (VVA) due to menopause.  When a woman goes through menopause, her body starts producing less estrogen, a…

CONTINUE READING

Stem Cell Studies for ED, Peyronie’s Encouraging, But More Research Needed

In recent years, many studies have investigated the use of stem cells in treatments for male sexual problems, such as erectile dysfunction (ED) and Peyronie’s disease. While many of these projects show some promise, further study is needed before such therapies can be deemed beneficial, according to a recent article in Sexual Medicine Reviews.  Current…

CONTINUE READING

FDA Issues Supplement Warnings

The U.S. Food and Drug Administration (FDA) recently announced recalls for many supplements marketed to men who seek sexual enhancement. In lab analyses, FDA officials found undeclared ingredients in the following products: African Viagra Big Penis Bl4ck 4K Capsules Black 3K Plus Black Mamba 2 Premium Duramaxxx Ginseng for Reinforcing Kidney Goldreallas Original Goldreallas XXX…

CONTINUE READING

Orgasm Problems: What Can Women Do?

Would it surprise you to learn that an estimated 10% to 40% of women have trouble reaching orgasm? And that some women have never had an orgasm at all? The clinical term is anorgasmia and it troubles many women. It can distress partners, too, who may think their bedroom skills are not up to par….

CONTINUE READING

Health Talk – Star Ledger of New Jersey features: Erectile Dysfunction – New Treatment with Low-Dose Shockwave Therapy

Erectile Dysfunction (ED), defined as the inability to obtain or maintain an erection, effects approximately 30 million men in the United States. Until recently, all treatment modalities for ED have been based on a symptom, not a cause. Now using regenerative medicine, the major cause of ED, which is poor blood flow, can be improved.  Stuart D….

CONTINUE READING

Study: Testosterone Therapy Does Not Increase Aggressive Prostate Cancer Risk

Testosterone replacement therapy (TRT) does not appear to increase a man’s risk for aggressive prostate cancer, according to a team of American and Swedish researchers.  The study, presented last month at the American Urological Association’s annual meeting in San Diego, California, examined almost a quarter-million medical records of Swedish men found in the National Prostate…

CONTINUE READING

Page 5 of 6« First...23456


Contact Us

(*) Fields Are Mandatory